Calocain en es it fr

Calocain Brand names, Calocain Analogs

Calocain Brand Names Mixture

  • No information avaliable

Calocain Chemical_Formula


Calocain RX_link

Calocain fda sheet

Calocain FDA

Calocain msds (material safety sheet)

Calocain MSDS

Calocain Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Calocain Molecular Weight

233.306 g/mol

Calocain Melting Point


Calocain H2O Solubility


Calocain State


Calocain LogP


Calocain Dosage Forms

Tablets; Tablets (sustained release)

Calocain Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Calocain Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Calocain Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Calocain side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Calocain Patient Information

Calocain Organisms Affected

Humans and other mammals